Biologie moléculaire : accès libre

CRISPR-Cas9 Mediated Gene Editing and its Impact on Cancer Immunotherapy

Abstract

Gemma Forner

CRISPR-Cas9 has revolutionized the field of genetic engineering with its precision and efficiency. This paper explores the application of CRISPRCas9 in cancer immunotherapy, focusing on its role in enhancing immune cell functions, targeting oncogenes, and overcoming resistance mechanisms. By modifying T cells and other immune components, CRISPR-Cas9 holds promise for developing more effective and personalized cancer treatments. We discuss recent advancements, potential challenges, and future directions in leveraging this technology for cancer immunotherapy.